Prestige Wealth Management Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92K	Hold	34	–	–	﹤0.01%	748
2025 Q4	$2.02K	Sell	34 -14	-29%	-$762	﹤0.01%	760
2025 Q3	$2.6K	Buy	48 +14	+41%	+$801	﹤0.01%	682
2025 Q2	$1.87K	Sell	34 -42	-55%	-$2.47K	﹤0.01%	748
2025 Q1	$5.37K	Buy	76 +42	+124%	+$2.83K	﹤0.01%	551
2024 Q4	$2.23K	Sell	34 -25	-42%	-$1.68K	﹤0.01%	761
2024 Q3	$4.15K	Buy	59 +25	+74%	+$2.09K	﹤0.01%	638
2024 Q2	$2.8K	Sell	34 -18	-35%	-$1.5K	﹤0.01%	654
2024 Q1	$4.54K	Sell	52 -64	-55%	-$5.73K	﹤0.01%	596
2023 Q4	$11.2K	Buy	116 +6	+5%	+$531	﹤0.01%	428
2023 Q3	$9.73K	Sell	110 -27	-20%	-$2.4K	﹤0.01%	445
2023 Q2	$11.9K	Hold	137	–	–	﹤0.01%	437
2023 Q1	$13.3K	Buy	137 +7	+5%	+$726	﹤0.01%	391
2022 Q4	$13.5K	Buy	130 +9	+7%	+$845	﹤0.01%	406
2022 Q3	$11K	Sell	121 -100	-45%	-$8.9K	﹤0.01%	402
2022 Q2	$19K	Buy	221 +72	+48%	+$5.73K	0.01%	335
2022 Q1	$11K	Hold	149	–	–	﹤0.01%	438
2021 Q4	$13K	Hold	149	–	–	﹤0.01%	438
2021 Q3	$11K	Buy	149 +12	+9%	+$947	﹤0.01%	462
2021 Q2	$11K	Buy	137 +16	+13%	+$1.27K	﹤0.01%	451
2021 Q1	$9K	Sell	121 -19	-14%	-$1.55K	﹤0.01%	488
2020 Q4	$12K	Buy	140 +73	+109%	+$5.79K	﹤0.01%	421
2020 Q3	$5K	Sell	67 -60	-47%	-$6.07K	﹤0.01%	531
2020 Q2	$16K	Buy	127 +64	+102%	+$6.36K	0.01%	361
2020 Q1	$5K	Buy	+63	New	+$5.43K	﹤0.01%	482
2019 Q1	–	Sell	-127	Closed	-$11K	–	574
2018 Q4	$11K	Buy	+127	New	+$12.1K	0.01%	410